ReviewCurrent hematologic malignancy reports2022
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma.
Arleigh McCurdy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it